Search

everythinglearnresearchcommunity

for

Search:↓

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

People with acne have more CD4+ immune cells in their skin than healthy people.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Immune system changes may contribute to female pattern hair loss.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Restoring hair follicle immune privilege may help treat alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

CS12192 effectively treats alopecia areata with better safety than current options.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

RIPK1 inhibitors might help prevent alopecia areata.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

IL-27 can prevent hair loss in alopecia areata.

Alopecia Areata can develop without perforin-mediated cytolysis.

taVNS reduces vitiligo symptoms in mice.